24小时热门版块排行榜    

查看: 289  |  回复: 1
本帖产生 1 个 翻译EPI ,点击这里进行查看

yin198716

新虫 (正式写手)

[求助] 请教翻译

However, there are a number of tumours that did not respond at all or responded in an early stage but became resistant in a late stage to VEGF inhibition in preclinical mouse models. In addition, anti-VEGF therapy alone appears to be ineffective in most, if not all, clinical trials. Thus, additional factors/pathways may directly drive tumour angiogenesis or switch on at certain stages to regulate tumour angiogenesis and growth in anti-VEGF-resistant tumours and combined approaches for interrupting the VEGF pathway and additi onal pathways may improve anti-angiogenic therapeutic efficacy.
Oncology
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

南京工大

木虫 (小有名气)

【答案】应助回帖

★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
爱与雨下: 金币+1 2013-04-15 19:33:55
sltmac: 金币+20, 翻译EPI+1, 感谢应助,欢迎常来 2013-05-20 09:44:10
但是,对于临床前期的鼠类模型的研究发现,许多的肿瘤对于VEGF抑制根本就没有响应,或是肿瘤在初期有响应,而在后期变得产生抗性。另外,单独采用抗VEGF的疗法对大多数的临床试验来讲都是无效的。因此,应该有其他的因素或是途径会直接导致肿瘤血管再生,或是在某个特定的阶段发挥效力,能够对抗VEGF理疗具有抗性的肿瘤进行调控,控制肿瘤血管再生和生长的过程;并能把影响VEGF的途径和其他能改善抗血管生成素疗法效果的途径结合起来。
2楼2013-04-12 22:47:39
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 yin198716 的主题更新
信息提示
请填处理意见